New drug shows promise for managing rare mast cell disease
NCT ID NCT07255638
First seen Dec 15, 2025 · Last updated May 23, 2026 · Updated 16 times
Summary
This study follows 80 adults in Germany with indolent systemic mastocytosis whose symptoms are not well controlled by current treatments. Researchers will track how well avapritinib works in real-world settings over up to 24 months, focusing on quality of life and symptom control. The goal is to better understand the drug's effectiveness and the disease's natural history.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INDOLENT SYSTEMIC MASTOCYTOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Charité Universitätmedizin Berlin, Klinik für Dermatologie, Venerologie und Allergologie
RECRUITINGBerlin, 10117, Germany
-
HNO-Gemeinschaftspraxis Wiesbaden, GEKA Gesellschaft für Experimentelle und Klinische Atemwegsforschung mbH, Zentrum für Rhinologie und Allergologie
RECRUITINGWiesbaden, 65205, Germany
-
Helios Universitätsklinikum Wuppertal
RECRUITINGWuppertal, 42283, Germany
-
Katholisches Klinikum Bochum
RECRUITINGBochum, 44791, Germany
-
MVZ Klinikum Deggendorf
RECRUITINGDeggendorf, 94469, Germany
-
Universitats-Hautklinik Tubingen, Studienzentrum lmmundermatologie
RECRUITINGTübingen, 72076, Germany
-
University Medical Center Goettingen - Georg August University of Goettingen
RECRUITINGGöttingen, 37075, Germany
-
Universitätsklinikum Carl Gustav Carus Dresden Klinik und Poliklinik für Dermatologie
RECRUITINGDresden, 01307, Germany
Conditions
Explore the condition pages connected to this study.